My issue was and remains lack of timelines and accountability....

My issue was and remains lack of timelines and accountability. Management appear to operate on a "best endeavours" basis and the Board does not appear to hold management to account. If you had not noticed, management are well paid - but thus far have not made shareholders rich - and lets not confuse hope with reality. We are all hoping that BNC 210 is The Big One. What if its a fizzer? We will have shelled out all these generous salaries and bonuses but received virtually nothing tangible to show for it. I can hear it now - we tried hard, we did our best, we thought we had a breakthrough........ Investing in biotech is risky - so brace yourself for news that may not set the world on fire - but by all means, hope for the best! GLTA